Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

David Johnson Einstein, M.D.

Concepts (125)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms82022105100.840 Why?
Terminal Care5201715910.820 Why?
Urogenital Neoplasms120201380.740 Why?
Androstenes220191750.730 Why?
Compassionate Use Trials12018430.720 Why?
Phenylurea Compounds120225550.720 Why?
Androgen Receptor Antagonists120191200.710 Why?
Quinolines120227240.640 Why?
Paternalism12016430.620 Why?
Carcinoma, Transitional Cell220217780.600 Why?
Death220175450.600 Why?
Receptors, Androgen2201910450.580 Why?
Telephone120196080.570 Why?
Advance Directives120162240.540 Why?
Empathy120184280.530 Why?
Personal Autonomy120162950.510 Why?
Kidney Neoplasms2202240100.500 Why?
Cisplatin1201916570.470 Why?
Physician-Patient Relations4202133000.460 Why?
Facial Paralysis120153180.430 Why?
Urinary Bladder Neoplasms2202120370.410 Why?
Carcinoma, Renal Cell2202229360.410 Why?
Vascular Endothelial Growth Factor A2202233940.400 Why?
Sarcoidosis120155060.400 Why?
African Americans2202251050.370 Why?
Neoplasm Recurrence, Local3202285890.370 Why?
Immunotherapy4202139100.360 Why?
CD8-Positive T-Lymphocytes2202141700.360 Why?
Cardiopulmonary Resuscitation120158420.350 Why?
Internal Medicine120159900.340 Why?
Palliative Care2202131760.310 Why?
Neoplasms52021196220.310 Why?
Internet1201930180.300 Why?
Medical Oncology1201719500.290 Why?
Drug Resistance, Neoplasm1202051440.280 Why?
Decision Making2201637670.270 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12022380.230 Why?
Thiohydantoins12021200.220 Why?
Phenylthiohydantoin220191990.210 Why?
Attitude of Health Personnel1201538200.210 Why?
Tumor Microenvironment2202127010.190 Why?
Antineoplastic Agents22021135690.190 Why?
Leuprolide120213140.190 Why?
Receptors, Vascular Endothelial Growth Factor120226510.180 Why?
Quality of Life12019110040.170 Why?
Sickness Impact Profile120193180.170 Why?
Nitriles220199470.160 Why?
Humans2620226858840.160 Why?
Urothelium120192940.160 Why?
Genes, Tumor Suppressor1202110880.150 Why?
Benzamides2201914120.150 Why?
Prednisone1202115490.150 Why?
Erythema Nodosum12015330.150 Why?
Internship and Residency1201553190.140 Why?
Lymphocytes, Tumor-Infiltrating1202110400.140 Why?
Prostatectomy2202118200.140 Why?
Serine120188320.130 Why?
Phylogeny1202127390.130 Why?
Drug Approval120228810.130 Why?
Renal Insufficiency120197800.120 Why?
Anecdotes as Topic12012550.120 Why?
Male1420223452990.120 Why?
Antineoplastic Agents, Hormonal1202115260.110 Why?
Angiogenesis Inhibitors1202220500.110 Why?
Androgen Antagonists1202013020.110 Why?
Ambulatory Care Facilities120178350.110 Why?
Hospice Care120175930.100 Why?
Professional-Patient Relations120167110.100 Why?
Neoplasm Invasiveness1201936380.100 Why?
Virus Diseases120156420.100 Why?
Xenograft Model Antitumor Assays1201836980.100 Why?
Prognosis32020284700.090 Why?
Biopsy1202166700.090 Why?
Survival Analysis22020104740.090 Why?
Culture120126370.090 Why?
Molecular Targeted Therapy1201928250.080 Why?
Gene Expression Regulation, Neoplastic2202085800.080 Why?
Neovascularization, Pathologic1201726870.080 Why?
Risk Assessment42021231520.070 Why?
Neoplasm Staging12019110240.060 Why?
Phenotype12021158810.060 Why?
Longitudinal Studies12019132540.060 Why?
Clinical Trials as Topic1201979410.060 Why?
Aged620211594750.060 Why?
Kidney1201766550.060 Why?
Antineoplastic Combined Chemotherapy Protocols22022110320.060 Why?
United States22022654030.050 Why?
Age Factors12019187690.050 Why?
Autocrine Communication120221860.050 Why?
Role120201780.050 Why?
RNA, Double-Stranded120212720.050 Why?
Diagnosis, Differential12015132390.050 Why?
Middle Aged520212117470.050 Why?
Preoperative Period120215280.050 Why?
Physicians1201641110.040 Why?
Prospective Studies22021493760.040 Why?
Combined Modality Therapy2202188280.040 Why?
Mice, Inbred ICR120183740.040 Why?
Interferons120216510.040 Why?
beta Catenin1202210420.040 Why?
Cohort Studies12019385480.040 Why?
Mutation12020285120.040 Why?
Epithelial-Mesenchymal Transition120206810.040 Why?
Perception1202111460.030 Why?
Signal Transduction12017236590.030 Why?
Female320173687810.030 Why?
Prostate1202015060.030 Why?
Mice, SCID1201828190.030 Why?
Immunologic Factors1202114910.030 Why?
Prostate-Specific Antigen1202022320.030 Why?
Neoadjuvant Therapy1202124440.030 Why?
Drug Therapy, Combination1202165180.030 Why?
Disease-Free Survival1202070240.020 Why?
Health Status Disparities1202016830.020 Why?
Animals220181667560.020 Why?
Patient Selection1202042430.020 Why?
Phosphorylation1201886390.020 Why?
Genomics1202049770.020 Why?
Treatment Outcome22021602000.020 Why?
Immunohistochemistry12018117570.020 Why?
Cell Line, Tumor12018167530.010 Why?
Adult120152078470.010 Why?
Cross-Sectional Studies12021219450.010 Why?
Follow-Up Studies12020388340.010 Why?
Tomography, X-Ray Computed12020199720.010 Why?
Einstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (125)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.